Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 4 1Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 5Carboplatin 5Docetaxel 4Cisplatin 4Bevacizumab 4Taxes 3Drug Therapy 3Gemcitabine 2Fluorodeoxyglucose F18 2Cetuximab 2saracatinib 1endostar protein 1cediranib 1aflutinib 1Zoledronic Acid 1X-Rays 1Vinorelbine 1Thoracic Surgery, Video-Assisted 1Spectrum Analysis 1Silver Nitrate 1Saline Solution 1Radiotherapy, Conformal 1Radiation 1Pleurodesis 1Pemetrexed 1Nivolumab 1Naproxen 1N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1Morphine 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pleural Effusion, Malignant × Pleurodesis × Clear all
NCT00644319 2009-07-08

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 2 Unknown
320 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡